What began as a scientific question in the lab is now a treatment for RA patients. Congratulations to the entire @SetPointMed team for developing the innovative device to stimulate the vagus nerve inflammatory reflex, and for sponsoring and leading the clinical trials with excellence, persistence, and compassion, culminating in FDA approval. This is a great journey in translational science, in collaboration with hundreds of people, all for the benefit of patients. Which is what the destination has been all along.

Congrats to @SetPointMed for proving the inflammatory reflex benefits patients with RA ! Now onto other autoimmune conditions.... "The study met its primary endpoint with a statistically significant greater proportion of study participants achieving an ACR20 response in the treatment group compared with the control group at 12 weeks (p=0.0209). An ACR20 response is a composite measure of the effectiveness for RA treatments set forth by the American College of Rheumatology." businesswire.com/news/home/2…

Data accumulates targeting the Vagus Nerve inflammatory reflex is giving hope for future options beyond biologics and JAK inhibitors. Is a tipping point approaching ? I really hope so. ⁦@PederOlofsson⁩ ⁦@ACRheum⁩ ⁦@SetPointMed⁩ the-rheumatologist.org/artic…